CLINICAL_TRIALS
research
· 2025-04-01
Clinical Trial Update: Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children [Phase 3]
Summary
This document updates on a Phase 3 clinical trial evaluating CAR-T cell therapy for refractory or recurrent lupus nephritis in children, which is currently recr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Guangzhou Women and Children's Medical Center | Conditions: Lupus Nephritis | Phase 3 | Status: RECRUITING